Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,527,653
-$2,524,205 QoQ
Shares Held
138,734
-3.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#343
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SHELTON CAPITAL MANAGEMENT holds $166,003,072 across 9 Drug Manufacturers - General names. GILD ranks #6 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
282,635 | $36,318,597 | |
| 2 | JNJ |
Johnson & Johnson
|
113,733 | $28,884,770 | |
| 3 | LLY |
ELI LILLY & Co
|
21,997 | $26,383,863 | |
| 4 | AMGN |
Amgen Inc
|
63,607 | $23,033,366 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
369,878 | $21,312,370 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
138,734 | $17,527,653 | |
| 7 | ABBV |
AbbVie Inc.
|
42,182 | $10,614,678 | |
| 8 | PFE |
Pfizer Inc
|
61,912 | $1,490,840 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,527,653 | 138,734 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $20,051,858 | 143,875 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,192,400 | 148,219 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,002,204 | 144,164 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,348,224 | 147,454 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $16,900,949 | 150,834 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,371,109 | 155,582 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $13,368,204 | 159,449 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,913,724 | 159,069 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $11,638,399 | 158,886 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,999,219 | 209,841 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $23,307,314 | 311,013 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $20,440,967 | 265,226 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $17,078,295 | 205,837 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,940,210 | 22,600 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,728,708 | 125,283 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,961,604 | 242,058 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $14,711,140 | 247,454 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $17,177,347 | 236,570 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $12,856,521 | 184,059 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $12,960,691 | 188,218 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $25,530,918 | 395,032 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $13,297,204 | 228,239 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $12,310,296 | 194,814 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $13,566,060 | 176,320 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $10,695,165 | 143,060 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||